Key Drivers
- Improved liquidity
- Moderate leverage
- Volatile FCF
AIAI Summary
STERIS has transitioned from a defensive cash generator into a premium‑valued growth/conviction trade — only hold or add if management delivers sustained mid‑to‑high single‑digit organic growth and a clear recovery of free cash flow to prior aggregate levels. The immediate actionable risk to monitor is volatile FCF and margin sensitivity (input/tariff pressures and large intangibles that raise impairment risk); require two consecutive quarters of FCF recovery and margin expansion as a buy/hold trigger, otherwise trim exposure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Improved liquidity
- •Moderate leverage
- •Volatile FCF
STE shows improved near-term liquidity and steady operating margins with moderate leverage but carries premium valuation, large intangible assets, and volatile free cash flow that heighten execution risk.
Price Behavior
Key Price Behavior Insights:
- •Below last-month SMA
- •RSI oversold
- •Resistance cluster
STE is in a short-term downtrend—closing at $220.03 below its last month average (~$233), deeply oversold (RSI ~23) with support at $212.35 and resistance around $247–255, so relief rallies are possible but the bias stays bearish until price clears that resistance.
Sharp negative momentum swing with a small bounce from the $212.35 low on 2026-03-12
Sentiment & News
Key News Insights:
- •Concentrated buys
- •Notable selloffs
- •Post-earnings dip
STERIS is seeing concentrated institutional buys from some managers paired with notable selloffs and a modest ~2.2% post‑earnings share dip.
Mixed institutional flows suggest ambiguous near‑term direction and could keep STERIS shares volatile despite no clear fundamental change
Similar Companies in Healthcare
Other companies in the same sector with AI ratings